SCHEMBL22818084

SCHEMBL22818084

c1ccc(-c2cccc(-c3cccc4oc5c6ccccc6c(N(c6ccccc6-c6ccccc6)c6cccc7c6oc6ccccc67)cc5c34)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.40
▸ GGPS1 O95749 1/20 0.35
▸ PLA2G2A P14555 3/20 0.33
▸ PLA2G4A P47712 3/20 0.33
▸ PTGES2 Q9H7Z7 1/20 0.33
▸ PRKDC P78527 4/20 0.32
▸ CDC14B O60729 1/20 0.32
▸ CDC14A Q9UNH5 1/20 0.32
▸ PLA2G10 O15496 1/20 0.32
▸ PIM1 P11309 1/20 0.30
▸ CSNK2A2 P19784 1/20 0.30
▸ CSNK2B P67870 1/20 0.30
▸ PIM3 Q86V86 1/20 0.30
▸ PIM2 Q9P1W9 1/20 0.30
▸ EPHX2 P34913 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22818278 0.95 ALOX5 (0.41) ALOX5GGPS1PLA2G2APLA2G4APTGES2
SCHEMBL22818065 0.95 ALOX5 (0.40) ALOX5GGPS1PTGES2PRKDCCDC14B
SCHEMBL22818149 0.91 ALOX5 (0.39) ALOX5GGPS1PTGES2PRKDCCDC14B
SCHEMBL22818116 0.90 ALOX5 (0.39) ALOX5GGPS1PLA2G2APLA2G4APTGES2
SCHEMBL22818093 0.90 ALOX5 (0.42) ALOX5GGPS1PLA2G2APLA2G4APTGES2
SCHEMBL22818121 0.90 ALOX5 (0.34) ALOX5GGPS1PLA2G2APLA2G4APRKDC
SCHEMBL22818164 0.90 ALOX5 (0.41) ALOX5GGPS1PLA2G2APLA2G4APTGES2
SCHEMBL27393269 0.90 ALOX5 (0.41) ALOX5GGPS1PLA2G2APLA2G4APTGES2
SCHEMBL22818192 0.90 ALOX5 (0.36) ALOX5GGPS1PLA2G2APLA2G4APTGES2
SCHEMBL15851667 0.90 ALOX5 (0.43) ALOX5GGPS1PTGES2PRKDCCDC14B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LT MATERIALS CO., LTD. (KR) 2020-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same CRY1, CRY2, PER2 ALOX5 1385/4885GGPS1 598/4885PLA2G2A 4271/4885
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, CRY2, PER2 ALOX5 1385/4885GGPS1 598/4885PLA2G2A 4271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback